ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2425

Pregnancy Outcomes Among Patients with Vasculitis Using Administrative Claims Data

Amadeia Rector1, Julia Simard2, Gary Shaw3 and Audra Horomanski4, 1Stanford University, San Francisco, CA, 2Department of Epidemiology & Population Health, Stanford University School of Medicine, Stanford, CA, 3Stanford University, Stanford, CA, 4Stanford University, Palo Alto, CA

Meeting: ACR Convergence 2023

Keywords: pregnancy, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Plenary III

Session Type: Plenary Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Systemic vasculitides are rare, heterogeneous, inflammatory disorders associated with high morbidity and mortality. Recent management and therapeutic advances have improved life expectancy and reproductive opportunities for vasculitis patients. Research on the risk of preterm delivery and maternal complications in these patients is limited. Therefore, we investigated pregnancy outcomes among patients with vasculitis leveraging large, administrative claims data.

Methods: Using administrative claims data from private health insurance providers we identified all pregnancies regardless of outcome for patients with and without vasculitis from 2007 to 2021. Vasculitis was defined as ≥2 ICD coded outpatient visits or ≥1 ICD coded inpatient visit occurring before the estimated last menstrual period (LMP). Vasculitis was further categorized by vessel size: large, medium, small, and variable based on Chapel Hill Consensus Conference criteria. As a referent population we included those without vasculitis or other rheumatic disease, defined as no ICD coded outpatient or inpatient visits for vasculitis, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, or juvenile idiopathic arthritis before LMP or during pregnancy. We described pregnancy outcomes in patients with vasculitis compared to the referent population. We also explored pregnancy characteristics and complications in patients with vasculitis stratified by parity (nulliparous vs multiparous).

Results: There were 665 pregnancies among 527 patients with vasculitis and 4,209,034 pregnancies among 2,932,379 patients from the referent population. Patients with vasculitis had a higher frequency of spontaneous abortion, elective termination, ectopic and molar pregnancy, and nearly two times as much preterm delivery compared to the referent population. Approximately 12% of pregnancies among patients with vasculitis were complicated by preeclampsia. Multiparous pregnancies compared to nulliparous had a slightly higher frequency of preterm delivery and were more often comorbid with gestational diabetes, pre-pregnancy hypertension, obesity, and hypothyroidism. Patients with small vessel vasculitis had higher frequencies of spontaneous abortion, preterm delivery, and comorbidities among vasculitis subtypes.

Conclusion: Pregnancies among patients with vasculitis had a higher frequency of spontaneous abortion and preterm delivery. Risk of maternal complications associated with vasculitis were observed to vary by vessel size and parity. These findings further the knowledge base and provide patients with up-to-date statistics on outcomes and complications.

Supporting image 1

Supporting image 2


Disclosures: A. Rector: None; J. Simard: None; G. Shaw: None; A. Horomanski: None.

To cite this abstract in AMA style:

Rector A, Simard J, Shaw G, Horomanski A. Pregnancy Outcomes Among Patients with Vasculitis Using Administrative Claims Data [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/pregnancy-outcomes-among-patients-with-vasculitis-using-administrative-claims-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pregnancy-outcomes-among-patients-with-vasculitis-using-administrative-claims-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology